TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.

被引：0
|
作者：
Yoneten, K. Karaosmanoglu [1 ]
Gunes, A. [2 ]
Kasap, M. [3 ]
Utkan, N. Z. [4 ]
Akpinar, G. [3 ]
Gurel, B. [5 ]
Guler, S. A. [4 ]
机构：
[1] Kocaeli Univ, Fac Technol, Dept Biomed Engn, Kocaeli, Turkey
[2] Derince Training & Res Hosp, Dept Gen Surg, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Med, Dept Med Biol, Kocaeli, Turkey
[4] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkey
[5] Kocaeli Univ, Fac Med, Dept Med Pathol, Kocaeli, Turkey
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2204
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The challenges of modeling hormone receptor-positive breast cancer in mice
    Ozdemir, Berna C.
    Sflomos, George
    Brisken, Cathrin
    ENDOCRINE-RELATED CANCER, 2018, 25 (05) : R319 - R330
  • [32] Understanding Resistance to Tamoxifen in Hormone Receptor-Positive Breast Cancer
    Higgins, Michaela J.
    Stearns, Vered
    CLINICAL CHEMISTRY, 2009, 55 (08) : 1453 - 1455
  • [33] Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer
    Yi, Zongbi
    Ma, Fei
    JOURNAL OF BREAST CANCER, 2017, 20 (04) : 321 - 326
  • [34] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [35] Overcoming endocrine resistance in hormone receptor-positive breast cancer
    AlFakeeh, A.
    Brezden-Masley, C.
    CURRENT ONCOLOGY, 2018, 25 : S18 - S27
  • [36] Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer.
    Cuzick, J
    Howell, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 43S - 43S
  • [37] Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Moore, Halle C. F.
    Maiti, Baidehi
    Rybicki, Lisa A.
    Booth, Christine
    Abraham, Jame
    Budd, G. Thomas
    Andresen, Steven Ware
    Downs-Kelly, Erinn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
  • [39] Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
    Freelander, Allegra
    Brown, Lauren J.
    Parker, Andrew
    Segara, Davendra
    Portman, Neil
    Lau, Brandon
    Lim, Elgene
    GENES, 2021, 12 (02) : 1 - 24
  • [40] A PhaseIITrial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases
    Xu, Jing
    Higgins, Michaela J.
    Tolaney, Sara M.
    Come, Steven E.
    Smith, Matthew R.
    Fornier, Monica
    Mahmood, Umar
    Baselga, Jose
    Yeap, Beow Y.
    Chabner, Bruce A.
    Isakoff, Steven J.
    ONCOLOGIST, 2020, 25 (08): : 652 - 660
12345